Detalhe da pesquisa
1.
Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Circ Genom Precis Med
; 11(4): e002069, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29615454
2.
CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention.
Pharmacogenomics
; 18(12): 1155-1166, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28745582
3.
Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patients.
Pharmacogenomics
; 16(4): 303-13, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25823779